과제정보
This paper was supported by Wonkwang Health Science University in 2021.
참고문헌
- Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol. 2001;88:980-986. https://doi.org/10.1016/s0002-9149(01)01974-9
- Zhao L, Song Y, Dong P, Li Z, Yang X, Wang S. Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: a meta-analysis of prospective observational studies. J Clin Hypertens (Greenwich). 2014;16:678-685. https://doi.org/10.1111/jch.12375
- Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol. 2010;55:1032-1037. https://doi.org/10.1016/j.jacc.2009.09.061
- Mazza A, Pessina AC, Gianluca P, Tikhonoff V, Pavei A, Casiglia E. Pulse pressure: an independent predictor of coronary and stroke mortality in elderly females from the general population. Blood Press. 2001;10:205-211. https://doi.org/10.1080/08037050152669710
- Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med. 2000;107:100-102,105-109,113-114. https://doi.org/10.3810/pgm.2000.02.869
- Nyblom H, Bjornsson E, Simren M, Aldenborg F, Almer S, Olsson R. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int. 2006;26:840-845. https://doi.org/10.1111/j.1478-3231.2006.01304.x
- Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis-epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122:129-139. https://doi.org/10.1007/s00508-010-1357-6
- Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013;34:2804-2811. https://doi.org/10.1093/eurheartj/eht246
- Glinghammar B, Rafter I, Lindstrom AK, Hedberg JJ, Andersson HB, Lindblom P, et al. Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int J Mol Med. 2009;23:621-631. https://doi.org/10.3892/ijmm_00000173
- Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore). 2016;95:e4821. https://doi.org/10.1097/MD.0000000000004821
- Yokoyama M, Watanabe T, Otaki Y, Takahashi H, Arimoto T, Shishido T, et al. Association of the aspartate aminotransferase to alanine aminotransferase ratio with BNP level and cardiovascular mortality in the general population: the yamagata study 10-year follow-up. Dis Markers. 2016;2016:4857917. https://doi.org/10.1155/2016/4857917
- Su TC, Chien KL, Jeng JS, Chang CJ, Hsu HC, Chen MF, et al. Pulse pressure, aortic regurgitation and carotid atherosclerosis: a comparison between hypertensives and normotensives. Int J Clin Pract. 2006;60:134-140. https://doi.org/10.1111/j.1742-1241.2006.00777.x
- Mancusi C, Losi MA, Izzo R, Canciello G, Carlino MV, Albano G, et al. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: the campania salute network. Eur J Prev Cardiol. 2018;25:235-243. https://doi.org/10.1177/2047487317747498
- Yoon H. Association between pulse pressure and impaired pulmonary function in non-smoking adults. Korean J Clin Lab Sci. 2020;52:119-127. https://doi.org/10.15324/kjcls.2020.52.2.119
- Roed T, Kristoffersen US, Knudsen A, Wiinberg N, Lebech AM, Almdal T, et al. Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C-a cross-sectional study. Vasc Health Risk Manag. 2014;10:55-62. https://doi.org/10.2147/VHRM.S53557
- Ostovaneh MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, Shah R, Murthy VL, et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circ Cardiovasc Imaging. 2018;11:e007241. https://doi.org/10.1161/CIRCIMAGING.117.007241
- Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44-48. https://doi.org/10.1111/j.1572-0241.1998.044_c.x
- Botros M, Sikaris KA. The de ritis ratio: the test of time. Clin Biochem Rev. 2013;34:117-130.
- Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G, et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore). 2016;95:e4821. https://doi.org/10.1097/MD.0000000000004821
- Vonbank A, Saely C, Rein P, Zanolin D, Leiherer A, Drexel H. The alanine aminotransferase/aspartate aminotransferase ratio predicts future cardiovascular events in patients with established coronary artery disease and homa insulin resistance. Atherosclerosis. 2016;252:e64-65. https://doi.org/10.1016/j.atherosclerosis.2016.07.445
- Rief P, Pichler M, Raggam R, Hafner F, Gerger A, Eller P, et al. The AST/ALT (De-Ritis) ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. Medicine (Baltimore). 2016;95:e3843. https://doi.org/10.1097/MD.0000000000003843
- Dart AM, Kingwell BA. Pulse pressure--a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37:975-984. https://doi.org/10.1016/s0735-1097(01)01108-1
- Verhave JC, Fesler P, du Cailar G, Ribstein J, Safar ME, Mimran A. Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension. 2005;45:586-591. https://doi.org/10.1161/01.HYP.0000158843.60830.cf
- Fagard RH, Pardaens K, Staessen JA, Thijs L. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol. 2001; 38:227-231. https://doi.org/10.1016/s0735-1097(01)01362-6
- Rizzo V, di Maio F, Petretto F, Marziali M, Bianco G, Barilla F, et al. Ambulatory pulse pressure, left ventricular hypertrophy and function in arterial hypertension. Echocardiography. 2004; 21:11-16. https://doi.org/10.1111/j.0742-2822.2004.02146.x
- White WB. Systolic versus diastolic blood pressure versus pulse pressure. Curr Cardiol Rep. 2002;4:463-467. https://doi.org/10.1007/s11886-002-0107-4
- Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8:6366. https://doi.org/10.1038/s41598-018-24875-1
- Larstorp AC, Ariansen I, Gjesdal K, Olsen MH, Ibsen H, Devereux RB, et al. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60:347-353. https://doi.org/10.1161/HYPERTENSIONAHA.112.195032
- Kucukseymen S, Cekin AH, Bayar N, Arslan S, Uygur Kucukseymen E, Mercan T, et al. A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease. PLoS One. 2018;13:e0190382. https://doi.org/10.1371/journal.pone.0190382
- Mantovani A, Zoppini G, Targher G, Golia G, Bonora E. Nonalcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals. J Endocrinol Invest. 2012;35:215-218. https://doi.org/10.1007/BF03345421
- Chen Y, Xu M, Wang T, Sun J, Sun W, Xu B, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015;241:145-150. https://doi.org/10.1016/j.atherosclerosis.2015.05.002
- Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with nonalcoholic fatty liver disease. J Hepatol. 2013;58:757-762. https://doi.org/10.1016/j.jhep.2012.11.015
- Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The association between non-invasive hepatic fibrosis markers and cardiometabolic risk factors in the framingham heart study. PLoS One. 2016;11:e0157517. https://doi.org/10.1371/journal.pone.0157517
- Abbas G, Silveira MG, Lindor KD. Hepatic fibrosis and the renin-angiotensin system. Am J Ther. 2011;18:e202-208. https://doi.org/10.1097/MJT.0b013e3181df8df5
- Kim G, Kim J, Lim YL, Kim MY, Baik SK. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review. Hepatol Int. 2016;10:819-828. https://doi.org/10.1007/s12072-016-9705-x
- Neves MF, Cunha AR, Cunha MR, Gismondi RA, Oigman W. The role of renin-angiotensin-aldosterone system and its new components in arterial stiffness and vascular aging. High Blood Press Cardiovasc Prev. 2018;25:137-145. https://doi.org/10.1007/s40292-018-0252-5
- Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res. 2003;26:609-614. https://doi.org/10.1291/hypres.26.609